X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

    Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

    Gavi, the Vaccine Alliance, Collaborates with Salesforce to Help Equitably Distribute Two Billion COVID-19 Vaccines by the End of 2021

    GSK and CureVac to develop next generation mRNA COVID-19 vaccines

    Oxford leads first trial investigating dosing with alternating vaccines

    Oxford leads first trial investigating dosing with alternating vaccines

    Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

    Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

    Merck, Pfizer get EU nod for Bavencio as bladder cancer maintenance

    Merck, Pfizer get EU nod for Bavencio as bladder cancer maintenance

    Boehringer Ingelheim and Enara Bio Partner on Cancer Immunotherapies

    Boehringer Ingelheim and Enara Bio Partner on Cancer Immunotherapies

    Pfizer’s new partnership focuses on digitising clinical trials

    Pfizer Invests $120 Million in Biotechnology Innovation

    DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India

    Baxter Biopharma Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine

    Pfizer and BioNTech Announce Agreement with the UK 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

    Baxter Biopharma Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

    Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

    Gavi, the Vaccine Alliance, Collaborates with Salesforce to Help Equitably Distribute Two Billion COVID-19 Vaccines by the End of 2021

    GSK and CureVac to develop next generation mRNA COVID-19 vaccines

    Oxford leads first trial investigating dosing with alternating vaccines

    Oxford leads first trial investigating dosing with alternating vaccines

    Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

    Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

    Merck, Pfizer get EU nod for Bavencio as bladder cancer maintenance

    Merck, Pfizer get EU nod for Bavencio as bladder cancer maintenance

    Boehringer Ingelheim and Enara Bio Partner on Cancer Immunotherapies

    Boehringer Ingelheim and Enara Bio Partner on Cancer Immunotherapies

    Pfizer’s new partnership focuses on digitising clinical trials

    Pfizer Invests $120 Million in Biotechnology Innovation

    DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India

    Baxter Biopharma Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine

    Pfizer and BioNTech Announce Agreement with the UK 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

    Baxter Biopharma Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Market Moves

NSF International Acquires Majority Interest in Amarex CRO

Content Team by Content Team
10th October 2019
in Market Moves
NSF International Acquires Majority Interest in Amarex CRO

NSF International has acquired a majority interest in Amarex Clinical Research, a clinical stage contract research organization (CRO) headquartered in Germantown, Maryland. The transaction supports NSF International’s mission of protecting and improving human health through expanded consulting services to the medical device and pharma/biotech industries. As part of NSF International’s global health science consulting business, the highly-respected CRO will be known as Amarex Clinical Research, an NSF International company.

Amarex Clinical Research will gain access to NSF International’s expert network and international scope. As part of NSF’s global network of locations, Amarex will continue to operate from its U.S. office near Washington, D.C. The company also operates an office in Taiwan and has a developing presence in Europe.

“NSF International plays an important role in the pharmaceutical and biotech industry as a champion of quality, scientific rigor and best practices aimed at protecting and improving human health. Together with Amarex, we are creating a single source for integrated, expert health science consulting services across the entire product lifecycle,” said NSF International President and CEO Kevan Lawlor. “Amarex brings clinical trial expertise to NSF International’s large base of training, quality and consulting clients, and Amarex’s CRO clients may now benefit from NSF International’s global reach and expertise in European Union Qualified Person and Medical Device Regulation training, chemistry manufacturing and controls support, and supplement testing inspection and certification.”

“Amarex is excited to join the NSF International family. Amarex will be able to leverage NSF International’s global infrastructure to expand our contract research capabilities and better serve clients with the design and execution of clinical trials and navigating the FDA, TFDA and EMA regulatory approval process,” said Amarex founder Dr. Kazem Kazempour, who will continue as president and CEO of Amarex, an NSF International company. “NSF International’s operational excellence will accelerate our expert team’s leap forward in the CRO market, and better help pharmaceutical, biotech and medical device/diagnostic companies develop products and services that will protect and improve human health while minimizing inefficiencies to save time and reduce unnecessary costs.”

Since 1998, Amarex Clinical Research has been helping biotech, medical device and pharmaceutical companies conduct scientifically sound clinical trials and navigate complex regulatory environments in a wide range of therapeutic indications, including oncology, central nervous system, wound healing, infectious disease, cardiovascular and urology.

As part of NSF International, Amarex will support companies with regulatory affairs, project/trial management, clinical operations, biostatistics, data management, pharmacovigilance, data monitoring committees, medical writing and consulting.

Previous Post

Amgen declares positive results for 2 Phase 3 BLINCYTO studies

Next Post

Adaptimmune, Cryoport Announce Agreement for Monitored Cell Therapies Transport

Related Posts

Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe
Market Moves

Biopharma Market to grow at 10.6% CAGR between 2020 and 2027

3rd December 2020
Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe
Market Moves

Antares Vision acquires pharma packaging leak specialist for $17.9m

20th July 2020
UCB Acquires Engage Therapeutics for $125M
Market Moves

UCB Acquires Engage Therapeutics for $125M

8th June 2020
Sygnature expands capabilities with acquisition of Alderley Oncology
Market Moves

Sygnature expands capabilities with acquisition of Alderley Oncology

4th June 2020
Sandoz Completes Acquisition of Aspens Japanese Operations
Market Moves

Sandoz Completes Acquisition of Aspens Japanese Operations

5th February 2020
Novartis to acquire The Medicines Company for USD 9.7 bn
Market Moves

Novartis to acquire The Medicines Company for USD 9.7 bn

26th November 2019
Next Post
Adaptimmune, Cryoport Announce Agreement for Monitored Cell Therapies Transport

Adaptimmune, Cryoport Announce Agreement for Monitored Cell Therapies Transport

Latest News

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate
Clinical Trials

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

4th February 2021
CSafe Global to present new Parcel and Cell & Gene thermal shipping solutions
News

CSafe Global Continues Expansion Across Asia with Two New Hub Locations in China

4th February 2021
Gavi, the Vaccine Alliance, Collaborates with Salesforce to Help Equitably Distribute Two Billion COVID-19 Vaccines by the End of 2021
Drug Development

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

4th February 2021
Oxford leads first trial investigating dosing with alternating vaccines
Drug Development

Oxford leads first trial investigating dosing with alternating vaccines

4th February 2021
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
Drug Development

Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

28th January 2021
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In